You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

neuroendocrine cancers

Showing 1 - 25 of 5,504
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SCLC, Small Cell Cancer, Advanced Solid Tumor Trial run by the NCI (Lurbinectedin, Berzosertib)

Recruiting
  • SCLC
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Neuroendocrine Tumors Trial (BI 764532, Carboplatin, Etoposide)

Not yet recruiting
  • Neuroendocrine Neoplasms
  • BI 764532
  • +3 more
  • (no location specified)
Nov 10, 2023

Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)

Not yet recruiting
  • Small Cell Lung Carcinoma
  • Neuroendocrine Neoplasms
  • BI 764532
  • (no location specified)
May 22, 2023

Neuroendocrine Cancer Trial in United States (Carfilzomib)

Completed
Has Results
  • Neuroendocrine Cancer
  • Denver, Colorado
  • +9 more
Jun 7, 2022

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Anal Squamous Cell Carcinoma, Colorectal Tumors, Soft Tissue Sarcoma Trial (Regorafenib in combination with Tislelizumab)

Not yet recruiting
  • Anal Squamous Cell Carcinoma
  • +7 more
  • Regorafenib in combination with Tislelizumab
  • (no location specified)
Oct 12, 2022

Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma

Recruiting
  • Bladder Small Cell Neuroendocrine Carcinoma
  • +16 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022

Advanced Biliary Tract Cancer, Neuroendocrine Tumors, Female Reproductive System Tumor Trial in Australia (Ipilimumab,

Recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Albury, New South Wales, Australia
  • +11 more
Oct 31, 2022

Intracranial Glioma, Metastatic Brain Tumor, Breast Cancer Trial in Detroit (1-(2-[18F]FLUOROETHYL)-L-Tryptophan)

Recruiting
  • Intracranial Glioma
  • +3 more
  • Detroit, Michigan
    Karmanos Cancer Institute
Sep 22, 2022

Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Adenocarcinoma Trial in Stanford (Serious Illness Conversation Guide

Terminated
  • Gastrointestinal Cancer
  • +8 more
  • Serious Illness Conversation Guide (SICG)
  • Quality of Life (QOL) survey
  • Stanford, California
    Stanford Cancer Center
Jan 25, 2023

Microsatellite High Cancers, Peritoneal Mesothelioma, Extrapulmonary High Grade Trial in Houston (XmAb20717)

Recruiting
  • Microsatellite High Cancers
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 8, 2022

Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

Not yet recruiting
  • Neuroendocrine Tumor (NET)
  • Colorectal Cancer (CRC)
  • CHM-2101 CAR-T cells
  • (no location specified)
Sep 20, 2023

Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

Recruiting
  • Gastric Cancer
  • +9 more
  • Tumor Infiltrating Lymphocytes (TIL)
  • Fludarabine + Cyclophosphamide combination
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 21, 2022

Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Young TIL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)

Completed
Has Results
  • Neuroendocrine Tumors
  • +2 more
  • Fort Myers, Florida
  • +12 more
Nov 16, 2021

Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,

Recruiting
  • Endocrine/Neuroendocrine
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Appendix Carcinoma, Colon Carcinoma, Esophageal Carcinoma Trial in Seattle (Acupuncture Therapy, Acupressure Therapy, Oral

Recruiting
  • Appendix Carcinoma
  • +12 more
  • Acupuncture Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Apr 11, 2022

Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston

Recruiting
  • Aggressive Variant Prostate Carcinoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 10, 2022

Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal

Recruiting
  • Gastric Cancers
    • Chicago, Illinois
      The University of Chicago
    May 12, 2021

    Carcinoid Cancer, Neuroendocrine Tumors, Medullary Thyroid Cancer Trial in Los Angeles (68Ga DOTATATE)

    No longer available
    • Carcinoid Cancer
    • +3 more
    • 68Ga DOTATATE
    • Los Angeles, California
      UCLA Hospital
    Jul 23, 2020

    Biliary Tract Tumors, Gastric Cancer, Esophageal Squamous Cell Carcinoma Trial in Beijing (FGFR Inhibitor, IDH1 Inhibitor, HER2

    Unknown status
    • Biliary Tract Neoplasms
    • +8 more
    • FGFR Inhibitor, IDH1 Inhibitor, HER2 Inhibitor, PARP Inhibitor, BRAF Inhibitor, MEK Inhibitor, ICIs, EGFR-TKIs, NTRK-TKI, and et. al.
    • Other Therapy
    • Beijing, Beijing, China
      Peking University Cancer Hospital
    Oct 8, 2020

    Head Neck Tumors, Neuroendocrine Tumors, Soft Tissue Sarcoma Trial in Meldola (Autologous DC vaccine, Interleukin-2)

    Recruiting
    • Head Neck Tumors
    • +4 more
    • Meldola, FC, Italy
      Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumor
    Apr 20, 2020

    Small-cell Lung Cancer, Neuroendocrine Carcinoma Trial (Iadademstat, Paclitaxel)

    Not yet recruiting
    • Small-cell Lung Cancer
    • Neuroendocrine Carcinoma
    • (no location specified)
    Jun 13, 2022

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023